DK0496796T3 - Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse - Google Patents
Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelseInfo
- Publication number
- DK0496796T3 DK0496796T3 DK90915877.6T DK90915877T DK0496796T3 DK 0496796 T3 DK0496796 T3 DK 0496796T3 DK 90915877 T DK90915877 T DK 90915877T DK 0496796 T3 DK0496796 T3 DK 0496796T3
- Authority
- DK
- Denmark
- Prior art keywords
- spin
- trapping
- administration
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/422,651 US5025032A (en) | 1989-10-17 | 1989-10-17 | Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage |
US58917790A | 1990-09-27 | 1990-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0496796T3 true DK0496796T3 (da) | 1994-10-03 |
Family
ID=27025701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90915877.6T DK0496796T3 (da) | 1989-10-17 | 1990-10-17 | Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse |
Country Status (12)
Country | Link |
---|---|
US (4) | US5405874A (fr) |
EP (1) | EP0496796B1 (fr) |
JP (5) | JP2620413B2 (fr) |
KR (1) | KR960008230B1 (fr) |
AT (1) | ATE110565T1 (fr) |
AU (4) | AU653921B2 (fr) |
CA (1) | CA2069961C (fr) |
DE (1) | DE69012138T2 (fr) |
DK (1) | DK0496796T3 (fr) |
ES (1) | ES2044829T3 (fr) |
HK (1) | HK1007281A1 (fr) |
WO (1) | WO1991005552A1 (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE110565T1 (de) * | 1989-10-17 | 1994-09-15 | Oklahoma Med Res Found | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. |
US5681845A (en) * | 1989-10-17 | 1997-10-28 | Oklahoma Medical Research Foundation | DMPO spin trapping compositions and methods of use thereof |
US6002001A (en) | 1991-06-18 | 1999-12-14 | Oklahoma Medical Research Foundation | Spin trapping pharmaceutical compositions and methods for use thereof |
ATE209908T1 (de) * | 1991-06-18 | 2001-12-15 | Oklahoma Med Res Found | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN |
US20050107366A1 (en) * | 1991-06-18 | 2005-05-19 | Carney John M. | Spin trapping pharmaceutical compositions and methods for use thereof |
TW257755B (fr) * | 1991-09-12 | 1995-09-21 | Merrell Dow Pharma | |
US5292746A (en) * | 1991-09-12 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock |
JPH0656669A (ja) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | 活性酸素消去作用を持つプテリン誘導体製剤 |
WO1995011908A1 (fr) * | 1993-10-25 | 1995-05-04 | Oklahoma Medical Research Foundation | Nouvelles compositions de pieges de spins phosphorees |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
FR2731428B1 (fr) * | 1995-03-06 | 1997-06-06 | Centre Nat Rech Scient | Derives phosphoryles de nitrones, leur procede de preparation et compositions les contenant |
IL123345A (en) * | 1995-09-11 | 2003-07-31 | Aventis Pharma Inc | Cyclic nitrones and pharmaceutical compositions containing them |
EP0888290B1 (fr) | 1995-11-17 | 2006-12-27 | Florida International University | Agents de piegeage de spin a base d'azulenyl-nitrones, et leurs procedes de fabrication et d'utilisation |
WO1997038683A1 (fr) * | 1996-04-17 | 1997-10-23 | Oklahoma Medical Research Foundation | Traitement de la demence associee a l'infection par le virus du sida (vih-1) au moyen de pieges a radicaux libres a base de nitrone |
AU721531B2 (en) * | 1996-04-23 | 2000-07-06 | Renovis, Inc. | Compositions comprising a nitrone compound for use in treating ocular inflammation |
US5900227A (en) * | 1996-06-17 | 1999-05-04 | Oklahoma Medical Research Foundation | Multicyclic nitrone spin trapping compositions |
IL128070A0 (en) * | 1996-07-19 | 1999-11-30 | Centaur Pharmaceuticals Inc | Furan nitrone compounds |
TW429241B (en) * | 1996-09-26 | 2001-04-11 | Sumitomo Pharma | Nitrone derivatives |
US6046232A (en) | 1997-10-17 | 2000-04-04 | Centaur Pharmaceuticals, Inc. | α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
CN1291980A (zh) * | 1998-01-16 | 2001-04-18 | 桑道药品有限公司 | 硫醚呋喃硝酮化合物 |
JP2002509147A (ja) * | 1998-01-16 | 2002-03-26 | センター ファーマシューティカルズ, インコーポレイテッド | チオフェンニトロン化合物 |
US6197826B1 (en) | 1998-07-17 | 2001-03-06 | Centaur Pharmaceuticals, Inc. | α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
UA66401C2 (en) | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
US6339102B1 (en) * | 1999-06-09 | 2002-01-15 | The United States Of America As Represented By The Secretary Of The Army | Method and composition for treating and preventing retinal damage |
AU785365B2 (en) * | 2000-03-30 | 2007-02-08 | Oklahoma Medical Research Foundation | Butylnitrone containing compositons for inhibition of cancer development |
SE0001916D0 (sv) * | 2000-05-23 | 2000-05-23 | Astrazeneca Ab | Novel formulation |
AU2002253857A1 (en) | 2001-01-08 | 2002-09-04 | Centaur Pharmaceuticals, Inc. | Use of aryl nitrone compounds in methods for treating neuropathic pain |
US20030045461A1 (en) * | 2001-09-06 | 2003-03-06 | Jen-Chang Hsia | Composition and methods of esterified nitroxides gated with carboxylic acids |
FR2846968B1 (fr) | 2002-11-08 | 2005-02-04 | Salles Jean Pierre | Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone |
US6762322B1 (en) * | 2002-12-20 | 2004-07-13 | Goodyear Tire & Rubber Company | Preparation of nitrone derivatives |
US20050059638A1 (en) * | 2003-08-04 | 2005-03-17 | Kelly Michael G. | Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
US20060235370A1 (en) * | 2005-04-04 | 2006-10-19 | Oblong John E | Method of regulating mammalian keratinous tissue |
US7125934B1 (en) | 2005-06-28 | 2006-10-24 | The Goodyear Tire & Rubber Company | Functionalization of living rubbery polymers with nitrones |
US8420595B2 (en) * | 2006-07-25 | 2013-04-16 | Oklahoma Medical Research Foundation | Methods for treating acute acoustic trauma |
EP2242360B1 (fr) | 2008-02-12 | 2015-04-08 | Tosk, Inc. | Adjuvants a la doxorubicine pour reduire la toxicite et leurs procedes d'utilisation |
WO2009110585A1 (fr) * | 2008-03-07 | 2009-09-11 | 国立大学法人熊本大学 | Solution échantillon pour la mesure de la résonance paramagnétique des électrons, solide séché de cette solution et procédé de mesure utilisant ces solution et solide |
EP2520716B1 (fr) * | 2009-04-20 | 2015-01-21 | Volvo Construction Equipment AB | Système et procédé de dallage intégré |
US9034926B2 (en) | 2010-12-30 | 2015-05-19 | Nicholas V. Perricone | Topical nitrone spin trap compositions for psoriasis |
US8986739B2 (en) | 2011-02-28 | 2015-03-24 | Nicholas V. Perricone | Treatment of urinary incontinence using nitrone spin traps |
ES2395803B1 (es) * | 2011-08-01 | 2013-12-19 | Consejo Superior De Investigaciones Científicas (Csic) - 80% | Quinolilnitronas |
DE102011088787A1 (de) | 2011-12-16 | 2013-06-20 | Evonik Industries Ag | Siloxannitrone und deren Anwendung |
WO2022169642A1 (fr) * | 2021-02-08 | 2022-08-11 | Oklahoma Medical Research Foundation | Okn-007 en tant qu'agent thérapeutique pour maladies neurodégénératives |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US35112A (en) * | 1862-04-29 | Improvement in head-rests for car-seats | ||
US35213A (en) * | 1862-05-13 | Improved hydrant | ||
DE273702C (fr) * | ||||
US3396027A (en) * | 1964-05-13 | 1968-08-06 | Eastman Kodak Co | Method of noodling gelatin dispersions |
NL131665C (fr) | 1964-05-18 | |||
US3296145A (en) * | 1965-10-21 | 1967-01-03 | Millmaster Onyx Corp | Quaternary ammonium-tertiary amine oxide compositions |
US3775122A (en) | 1967-07-28 | 1973-11-27 | American Can Co | Image production using photosensitive compositions of nitrone which is heat developed |
US3834073A (en) * | 1971-05-03 | 1974-09-10 | Scm Corp | Phenyl nitrone derivatives useful as seed protectants |
US3849934A (en) * | 1971-05-03 | 1974-11-26 | Scm Corp | Alpha-aryl-n-lower alkyl nitrone-containing compositions useful as anti-fungal agents |
US3767818A (en) | 1971-05-03 | 1973-10-23 | Scm Corp | Phenyl nitrone containing compositions useful as anti microbial agents |
GB1531278A (en) * | 1975-12-15 | 1978-11-08 | Shionogi & Co | 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof |
GB1588417A (en) * | 1977-03-15 | 1981-04-23 | Agfa Gevaert | Photoresist materials |
US4153722A (en) * | 1977-10-06 | 1979-05-08 | William H. Rorer, Inc. | Method of treatment |
US4214003A (en) * | 1977-10-06 | 1980-07-22 | William H. Rorer, Inc. | Method of treatment |
US4197314A (en) * | 1977-10-06 | 1980-04-08 | William H. Rorer, Inc. | Method of treating inflammation |
US4224340A (en) * | 1977-10-06 | 1980-09-23 | William H. Rorer, Inc. | Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds |
US4870002A (en) * | 1981-04-07 | 1989-09-26 | The United States Of America As Represented By The Secretary Of The Air Force | Method of prevention of oxidative injury to cells |
WO1988005044A1 (fr) * | 1986-12-29 | 1988-07-14 | Pharmacia Ab | Composes d'oxyde nitreux pour la preparation d'une composition pharmaceutique destinee a la prophylaxie et au traitement de troubles causes par des cellules ischemiques |
WO1988005653A1 (fr) * | 1987-01-28 | 1988-08-11 | Proctor Peter H | Composition a application locale et procede de stimulation de la croissance des cheveux avec des radicaux libres stables |
US5025032A (en) * | 1989-10-17 | 1991-06-18 | Oklahoma Medical Research Foundation | Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage |
ATE110565T1 (de) * | 1989-10-17 | 1994-09-15 | Oklahoma Med Res Found | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
-
1990
- 1990-10-17 AT AT90915877T patent/ATE110565T1/de not_active IP Right Cessation
- 1990-10-17 ES ES90915877T patent/ES2044829T3/es not_active Expired - Lifetime
- 1990-10-17 AU AU66133/90A patent/AU653921B2/en not_active Ceased
- 1990-10-17 EP EP90915877A patent/EP0496796B1/fr not_active Expired - Lifetime
- 1990-10-17 JP JP2515036A patent/JP2620413B2/ja not_active Expired - Fee Related
- 1990-10-17 WO PCT/US1990/005952 patent/WO1991005552A1/fr active IP Right Grant
- 1990-10-17 KR KR1019920700900A patent/KR960008230B1/ko not_active IP Right Cessation
- 1990-10-17 DE DE69012138T patent/DE69012138T2/de not_active Expired - Fee Related
- 1990-10-17 DK DK90915877.6T patent/DK0496796T3/da active
- 1990-10-17 CA CA002069961A patent/CA2069961C/fr not_active Expired - Fee Related
-
1993
- 1993-03-05 US US08/027,559 patent/US5405874A/en not_active Expired - Lifetime
-
1994
- 1994-12-28 US US08/365,548 patent/US5578617A/en not_active Expired - Fee Related
-
1995
- 1995-01-20 AU AU11315/95A patent/AU692197B2/en not_active Ceased
- 1995-06-06 US US08/468,563 patent/US6107315A/en not_active Expired - Fee Related
- 1995-06-06 US US08/468,561 patent/US5681965A/en not_active Expired - Fee Related
-
1996
- 1996-07-09 JP JP8179709A patent/JP2816326B2/ja not_active Expired - Fee Related
-
1998
- 1998-03-25 JP JP10077984A patent/JP2975587B2/ja not_active Expired - Fee Related
- 1998-03-25 JP JP10077985A patent/JPH10259128A/ja active Pending
- 1998-06-24 HK HK98106466A patent/HK1007281A1/xx not_active IP Right Cessation
- 1998-09-04 AU AU83101/98A patent/AU710341B2/en not_active Ceased
- 1998-09-04 AU AU83102/98A patent/AU710342B2/en not_active Ceased
-
2001
- 2001-11-08 JP JP2001343709A patent/JP2002179563A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH10259178A (ja) | 1998-09-29 |
AU710341B2 (en) | 1999-09-16 |
HK1007281A1 (en) | 1999-04-09 |
ES2044829T3 (es) | 1995-01-16 |
AU6613390A (en) | 1991-05-16 |
JPH0925263A (ja) | 1997-01-28 |
CA2069961A1 (fr) | 1991-04-18 |
KR920702220A (ko) | 1992-09-03 |
DE69012138D1 (de) | 1994-10-06 |
US5578617A (en) | 1996-11-26 |
ES2044829T1 (es) | 1994-01-16 |
JP2975587B2 (ja) | 1999-11-10 |
JP2620413B2 (ja) | 1997-06-11 |
AU710342B2 (en) | 1999-09-16 |
EP0496796A1 (fr) | 1992-08-05 |
JP2002179563A (ja) | 2002-06-26 |
AU1131595A (en) | 1995-03-23 |
AU692197B2 (en) | 1998-06-04 |
US5405874A (en) | 1995-04-11 |
CA2069961C (fr) | 2000-05-02 |
JPH05505792A (ja) | 1993-08-26 |
WO1991005552A1 (fr) | 1991-05-02 |
JP2816326B2 (ja) | 1998-10-27 |
AU8310198A (en) | 1998-12-24 |
DE69012138T2 (de) | 1995-04-06 |
US6107315A (en) | 2000-08-22 |
EP0496796B1 (fr) | 1994-08-31 |
KR960008230B1 (ko) | 1996-06-21 |
AU653921B2 (en) | 1994-10-20 |
AU8310298A (en) | 1998-10-22 |
US5681965A (en) | 1997-10-28 |
JPH10259128A (ja) | 1998-09-29 |
ATE110565T1 (de) | 1994-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0496796T3 (da) | Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse | |
NO884625D0 (no) | N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel. | |
NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
FR2612187B1 (fr) | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant | |
DK0828728T3 (da) | Phenyldihydrobenzofuraner | |
YU47116B (sh) | Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
DE59610031D1 (de) | Cyclohexyldihydrobenzofurane | |
SE9401197D0 (sv) | Active compounds | |
IL85228A (en) | 1-(4-hydroxy-3,5-di-tert.- butylbenzoyl) homopiperazine, various derivatives thereof, processes for the preparation of these and pharmaceutical compositions containing them | |
DK122391D0 (da) | Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
DK393188D0 (da) | Farmaceutisk praeparat til intranasal administrering | |
NO912414L (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
PT1147105E (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares | |
NO173184C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-2,4- og 2,5-dikarboksylsyrederivater | |
RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
DK1115697T3 (da) | Umættede hydroximsyrederivater som PARP-inhibitorer | |
BR9910449A (pt) | Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridina | |
DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf | |
DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
NO893256L (no) | Fremgangsmaate for fremstilling av furyltiazolderivater. | |
DK0486586T3 (da) | Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem | |
ATE91414T1 (de) | Hustenstillende zusammensetzungen und ein verfahren zu deren herstellung. | |
ATE92924T1 (de) | Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. |